Despite advances in diagnosis and management, ischemic heart disease remain
s the leading cause of death in the USA. Serum cardiac enzymes, one of the
three fundamental criteria for establishing the diagnosis of myocardial inf
arction, are not specific for cardiac muscle and have a narrow time-window.
The recent development of monoclonal antibodies to cardiac troponin I and
troponin T has resulted in cardiac-specific assays. Several published studi
es have documented the utility of troponin proteins in the evaluation of my
ocardial necrosis. A brief overview of the characteristics and clinical uti
lity of troponin T and I is presented here.